Moxibustion for prehypertension and stage I hypertension: a pilot randomized controlled trial.

ABSTRACT:

Background

Prehypertension and hypertension are associated with cardiovascular disease, ischemic heart disease, and stroke morbidity. The purpose of this study is to evaluate the effectiveness and safety of moxibustion in patients with prehypertension or hypertension.

Methods

Forty-five subjects with prehypertension or stage I hypertension were randomized into three groups: moxibustion treatment group A (2 sessions/week for 4 weeks), moxibustion treatment group B (3 sessions/week for 4 weeks), and control group (nontreated group). The primary outcome measure was the change in blood pressure after 4 weeks of treatment. Safety was assessed at every visit.

Results

There were no significant differences in systolic blood pressure (SBP) or diastolic blood pressure (DBP) amo

SUBMITTER: Shin KM 

PROVIDER: S-EPMC6309023 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature